AIM
ACHV icon

Alambic Investment Management’s Achieve Life Sciences ACHV Stock Holding History

Alambic Investment Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-57
Closed -$153K – 482
2015
Q4 		$153K Buy
+57
New +$241K 0.09% 304

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alambic Investment Management's ACHV Position: Q1 2016 in Review

Alambic Investment Management sold out of Achieve Life Sciences (ACHV) in Q1 2016, closing a stake of 57 shares — an estimated $153K sold.

Alambic Investment Management first reported a position in ACHV in Q4 2015 and held it in 1 quarter. The position peaked at $153K in Q4 2015. 38 funds tracked by Wall St. Rank hold ACHV as of Q1 2016.

  • Alambic Investment Management reported no remaining Achieve Life Sciences position as of Q1 2016 after selling out during the quarter.
  • Alambic Investment Management sold 57 Achieve Life Sciences shares in Q1 2016, an estimated $153K.
  • Alambic Investment Management first reported a position in Achieve Life Sciences in Q4 2015 and held it in 1 quarter.
  • Alambic Investment Management's Achieve Life Sciences position peaked at $153K in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2016.

Based on Alambic Investment Management's 13F filing for Q1 2016, filed 5 May 2016.